Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Saeedeh Ghorbanalipoor; Shirin Emtenani; Melissa Parker; Mayumi Kamaguchi; Colin Osterloh; Manuela Pigors; Natalie Gross; Stanislav Khil’chenko; Anika Kasprick; Sabrina Patzelt; Diana Wortmann; Ibrahim O. Ibrahim; Kentaro Izumi; Stephanie Goletz; Katharina Boch; Kathrin Kalies; Katja Bieber; Paul Smith; Enno Schmidt; Ralf J. Ludwig

doi:10.3389/fimmu.2022.1099535

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Saeedeh Ghorbanalipoor
, Shirin Emtenani
, Melissa Parker
, Mayumi Kamaguchi
, Colin Osterloh
, Manuela Pigors
, Natalie Gross
, Stanislav Khil’chenko
, Anika Kasprick
, Sabrina Patzelt
, Diana Wortmann
, Ibrahim O. Ibrahim
, Kentaro Izumi
, Stephanie Goletz
, Katharina Boch
, Kathrin Kalies
, Katja Bieber
, Paul Smith
, Enno Schmidt
, Ralf J. Ludwig^*

^*Corresponding author for this work

Incyte Research Institute
Connect Biopharma

4 Citations (Scopus)

Abstract

In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

Original language	English
Article number	1099535
Journal	Frontiers in Immunology
Volume	13
ISSN	1664-3224
DOIs	https://doi.org/10.3389/fimmu.2022.1099535
Publication status	Published - 30.11.2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

2.21-05 Immunology
2.22-19 Dermatology

Access to Document

10.3389/fimmu.2022.1099535

Fingerprint

Dive into the research topics of 'Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)'. Together they form a unique fingerprint.

CRC 1526, PANTAU: Pathomechanisms of Antibody-mediated Autoimmunity
Sadik, C. (Speaker), Zillikens, D. (Speaker), Scheffold, A. (Principal Investigator (PI)), Schmidt, E. (Principal Investigator (PI)), Heine, G. (Principal Investigator (PI)), Manz, R. (Principal Investigator (PI)), Köhl, J. (Principal Investigator (PI)), Ludwig, R. (Principal Investigator (PI)), Peipp, M. (Principal Investigator (PI)), Hammers, M. C. (Principal Investigator (PI)), Verschoor, A. (Principal Investigator (PI)), Karsten, C. (Principal Investigator (PI)), Nimmerjahn, F. (Principal Investigator (PI)), Hutloff, A. (Principal Investigator (PI)), Ibrahim, S. (Principal Investigator (PI)), Wettschureck, N. (Principal Investigator (PI)), Bieber, K. (Principal Investigator (PI)), Schilf, P. (Principal Investigator (PI)), Vaeth, M. (Principal Investigator (PI)), Hirose, M. (Principal Investigator (PI)), Vaeth, M. (Principal Investigator (PI)), Baines, J. F. (Principal Investigator (PI)), Bacher, P. (Principal Investigator (PI)), Hoffmann, M. (Principal Investigator (PI)), Busch, H. S. (Principal Investigator (PI)), Höppner, M. (Principal Investigator (PI)), Becker, M. (Principal Investigator (PI)), Holtsche, M. M. (Principal Investigator (PI)), Fähnrich, A. (Principal Investigator (PI)), Szymczak, S. (Principal Investigator (PI)), Murthy, S. (Principal Investigator (PI)) & Lux, A. (Principal Investigator (PI))
01.01.22 → 31.12.27
Project: DFG Joint Research › DFG Collaborative Research Centers (CRC)

Cite this

Ghorbanalipoor, S., Emtenani, S., Parker, M., Kamaguchi, M., Osterloh, C., Pigors, M., Gross, N., Khil’chenko, S., Kasprick, A., Patzelt, S., Wortmann, D., Ibrahim, I. O., Izumi, K., Goletz, S., Boch, K., Kalies, K., Bieber, K., Smith, P., Schmidt, E., & Ludwig, R. J. (2022). Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241). Frontiers in Immunology, 13, Article 1099535. https://doi.org/10.3389/fimmu.2022.1099535

@article{e03df55312534121906cc42fdf3f09a9,

title = "Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)",

abstract = "In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.",

author = "Saeedeh Ghorbanalipoor and Shirin Emtenani and Melissa Parker and Mayumi Kamaguchi and Colin Osterloh and Manuela Pigors and Natalie Gross and Stanislav Khil{\textquoteright}chenko and Anika Kasprick and Sabrina Patzelt and Diana Wortmann and Ibrahim, \{Ibrahim O.\} and Kentaro Izumi and Stephanie Goletz and Katharina Boch and Kathrin Kalies and Katja Bieber and Paul Smith and Enno Schmidt and Ludwig, \{Ralf J.\}",

note = "Publisher Copyright: {\textcopyright} 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil{\textquoteright}chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.",

year = "2022",

month = nov,

day = "30",

doi = "10.3389/fimmu.2022.1099535",

language = "English",

volume = "13",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

Ghorbanalipoor, S , Emtenani, S, Parker, M, Kamaguchi, M, Osterloh, C , Pigors, M , Gross, N, Khil’chenko, S, Kasprick, A , Patzelt, S, Wortmann, D, Ibrahim, IO, Izumi, K, Goletz, S, Boch, K, Kalies, K , Bieber, K, Smith, P, Schmidt, E & Ludwig, RJ 2022, 'Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)', Frontiers in Immunology, vol. 13, 1099535. https://doi.org/10.3389/fimmu.2022.1099535

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241). / Ghorbanalipoor, Saeedeh ; Emtenani, Shirin; Parker, Melissa et al.
In: Frontiers in Immunology, Vol. 13, 1099535, 30.11.2022.

Research output: Journal Articles › Comments/Debates

TY - JOUR

T1 - Corrigendum to

T2 - Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

AU - Ghorbanalipoor, Saeedeh

AU - Emtenani, Shirin

AU - Parker, Melissa

AU - Kamaguchi, Mayumi

AU - Osterloh, Colin

AU - Pigors, Manuela

AU - Gross, Natalie

AU - Khil’chenko, Stanislav

AU - Kasprick, Anika

AU - Patzelt, Sabrina

AU - Wortmann, Diana

AU - Ibrahim, Ibrahim O.

AU - Izumi, Kentaro

AU - Goletz, Stephanie

AU - Boch, Katharina

AU - Kalies, Kathrin

AU - Bieber, Katja

AU - Smith, Paul

AU - Schmidt, Enno

AU - Ludwig, Ralf J.

N1 - Publisher Copyright: © 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil’chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.

PY - 2022/11/30

Y1 - 2022/11/30

N2 - In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

AB - In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

UR - https://www.scopus.com/pages/publications/85144017387

U2 - 10.3389/fimmu.2022.1099535

DO - 10.3389/fimmu.2022.1099535

M3 - Comments/Debates

C2 - 36532003

AN - SCOPUS:85144017387

SN - 1664-3224

VL - 13

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1099535

ER -

Ghorbanalipoor S , Emtenani S, Parker M, Kamaguchi M, Osterloh C , Pigors M et al. Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241). Frontiers in Immunology. 2022 Nov 30;13:1099535. doi: 10.3389/fimmu.2022.1099535

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Abstract

UN SDGs

Research Areas and Centers

DFG Research Classification Scheme

Access to Document

Other files and links

Fingerprint

Projects

CRC 1526, PANTAU: Pathomechanisms of Antibody-mediated Autoimmunity

Cite this